SHIFT AI Newsroom · GLOBAL
Trevogrumab and Garetosmab with Semaglutide in Clinical Trial for Obesity
A clinical trial is investigating the safety and efficacy of Trevogrumab and Garetosmab with Semaglutide for weight loss, fat loss, and lean mass preservation in adult patients with obesity.
A clinical trial has been registered to study the combination of Trevogrumab and Garetosmab with Semaglutide for obesity treatment. The trial aims to investigate the safety and efficacy of this combination for weight loss, fat loss, and lean mass preservation in adult patients with obesity.
What this means in the UK
This trial may potentially lead to new treatment options for obesity in the UK, but its impact and availability in the UK are currently unknown.
Known facts
- A clinical trial is investigating the safety and efficacy of Trevogrumab and Garetosmab with Semaglutide for obesity treatment.